Evotec (Chemical Development Business) Overview

  • Status
  • Acquired/​Merged
  • Employees
  • 210
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Evotec (Chemical Development Business) General Information

Description

Developer of new drugs. The company offers integrated drug discovery services and alliances to the pharmaceutical and biotechnology industry.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • Schnackenburgallee 114
  • 22525 Hamburg
  • Germany
+49 040 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Evotec (Chemical Development Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Evotec (Chemical Development Business)‘s full profile, request access.

Request a free trial

Evotec (Chemical Development Business) Executive Team (1)

Name Title Board Seat Contact Info
Paul McGee Head
To view Evotec (Chemical Development Business)’s complete executive team members history, request access »

Evotec (Chemical Development Business) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Evotec (Chemical Development Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Evotec (Chemical Development Business)‘s full profile, request access.

Request a free trial